Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription


4 Anticancer Res
2 BJU Int
3 BMC Urol
1 Br J Cancer
3 Br J Radiol
2 Clin Cancer Res
1 Clin Imaging
2 Eur Urol
1 Int J Cancer
2 Int J Radiat Oncol Biol Phys
2 J Magn Reson Imaging
1 J Urol
1 Mod Pathol
1 Nat Rev Urol
1 Oncogene
1 Oncol Rep
1 PLoS One
2 Urol Int
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Anticancer Res

  1. JIMENEZ ROMERO ME, Gallego MC, Navarro Serrato JC, Sanchez Hurtado MA, et al
    Treatment of Metastatic Castration-resistant Prostate Cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors.
    Anticancer Res. 2021;41:3955-3968.
    PubMed         Abstract available

  2. BLAS L, Shiota M, Yamada S, Ieiri K, et al
    Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer.
    Anticancer Res. 2021;41:3885-3889.
    PubMed         Abstract available

  3. WATANABE H, Kawakami A, Sato R, Watanabe K, et al
    Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
    Anticancer Res. 2021;41:3753-3758.
    PubMed         Abstract available

  4. OELRICH F, Junker H, Stope MB, Erb HHH, et al
    Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery.
    Anticancer Res. 2021;41:3717-3729.
    PubMed         Abstract available

    BJU Int

  5. BUELENS S, Poelaert F, Claeys T, De Bleser E, et al
    Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Study.
    BJU Int. 2021 Jul 21. doi: 10.1111/bju.15553.
    PubMed         Abstract available

  6. KAMRAN SC, Zietman AL
    Radiation Treatment in Prostate Cancer: Covering the Waterfront.
    BJU Int. 2021 Jul 17. doi: 10.1111/bju.15550.
    PubMed         Abstract available

    BMC Urol

  7. SHIM JW, Cho YJ, Moon HW, Park J, et al
    Analgesic efficacy of intrathecal morphine and bupivacaine during the early postoperative period in patients who underwent robotic-assisted laparoscopic prostatectomy: a prospective randomized controlled study.
    BMC Urol. 2021;21:30.
    PubMed         Abstract available

  8. PANE-ALEMANY R, Ramirez-Garcia I, Carralero-Martinez A, Blanco-Ratto L, et al
    Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol.
    BMC Urol. 2021;21:12.
    PubMed         Abstract available

  9. NOMURA S, Toyama Y, Akatsuka J, Endo Y, et al
    Prostatic abscess with infected aneurysms and spondylodiscitis after transrectal ultrasound-guided prostate biopsy: a case report and literature review.
    BMC Urol. 2021;21:11.
    PubMed         Abstract available

    Br J Cancer

  10. ZHAO Z, Zhao S
    Reply to Comment on "miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition".
    Br J Cancer. 2021 Jul 20. pii: 10.1038/s41416-021-01493.

    Br J Radiol

  11. ZHANG L, Jiang D, Chen C, Yang X, et al
    Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
    Br J Radiol. 2021 Jul 21:20210191. doi: 10.1259/bjr.20210191.
    PubMed         Abstract available

  12. BENHMIDA S, Beneux A, Udrescu C, Rouviere O, et al
    Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Br J Radiol. 2021 Jul 20:20210142. doi: 10.1259/bjr.20210142.
    PubMed         Abstract available

  13. MAZZOLA R, Sicignano G, Cuccia F, Vitale C, et al
    Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
    Br J Radiol. 2021 Jul 20:20210521. doi: 10.1259/bjr.20210521.
    PubMed         Abstract available

    Clin Cancer Res

  14. MURTOLA TJ, Siltari A
    Statins for prostate cancer: when and how much?
    Clin Cancer Res. 2021 Jul 19. pii: 1078-0432.CCR-21-1891.
    PubMed         Abstract available

  15. SARKER D, Dawson NA, Aparicio AM, Dorff TB, et al
    A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kbeta inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Clin Cancer Res. 2021 Jul 19. pii: 1078-0432.CCR-21-1115.
    PubMed         Abstract available

    Clin Imaging

  16. AKCAY A, Yagci AB, Celen S, Ozlulerden Y, et al
    VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Clin Imaging. 2021;77:25-36.
    PubMed         Abstract available

    Eur Urol

  17. ATTARD G, Brown LC, Clarke NW, Parmar MKB, et al
    Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE Trial.
    Eur Urol. 2021 Jul 14. pii: S0302-2838(21)01864.

  18. STERNBERG CN, Castellano D, de Bono J, Fizazi K, et al
    Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study.
    Eur Urol. 2021 Jul 14. pii: S0302-2838(21)01862.
    PubMed         Abstract available

    Int J Cancer

  19. WEITZER J, Castano-Vinyals G, Aragones N, Gomez-Acebo I, et al
    Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain Study).
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33310.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  20. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed         Abstract available

  21. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2021;109:718-725.
    PubMed         Abstract available

    J Magn Reson Imaging

  22. CUOCOLO R, Comelli A, Stefano A, Benfante V, et al
    Deep Learning Whole-Gland and Zonal Prostate Segmentation on a Public MRI Dataset.
    J Magn Reson Imaging. 2021 Feb 26. doi: 10.1002/jmri.27585.
    PubMed         Abstract available

    Could AI Assistance Close the PI-RADS Variability Gap?
    J Magn Reson Imaging. 2021;54:484-485.

    J Urol

    Urological Oncology: Prostate Cancer.
    J Urol. 2021 Jul 20:101097JU0000000000002132. doi: 10.1097/JU.0000000000002132.

    Mod Pathol

  25. ZHU MMT, Burugu S, Gao D, Yu J, et al
    Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
    Mod Pathol. 2020 Apr 29. pii: 10.1038/s41379-020-0550.
    PubMed         Abstract available

    Nat Rev Urol

  26. WANG Y, Wang Y, Ci X, Choi SYC, et al
    Molecular events in neuroendocrine prostate cancer development.
    Nat Rev Urol. 2021 Jul 21. pii: 10.1038/s41585-021-00490.
    PubMed         Abstract available


  27. LIU C, Armstrong CM, Ning S, Yang JC, et al
    ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling.
    Oncogene. 2021 Jul 16. pii: 10.1038/s41388-021-01914.
    PubMed         Abstract available

    Oncol Rep

  28. DU W, Li D, Xie J, Tang P, et al
    miR3673p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

    PLoS One

  29. ARIK A, Dodd E, Cairns A, Streftaris G, et al
    Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality.
    PLoS One. 2021;16:e0253854.
    PubMed         Abstract available

    Urol Int

  30. SHEN Q, Zhou Z, Liu Z, Hu S, et al
    Clinical and Pathological Features of Prostatic Stromal Tumor of Uncertain Malignant Potential: A Retrospective Study of 23 Chinese Cases.
    Urol Int. 2021;105.
    PubMed         Abstract available

  31. MAURER V, Stahlberg J, Schiffmann I, Marks P, et al
    Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database.
    Urol Int. 2021;105.
    PubMed         Abstract available


  32. SESSINE MS, Das S, Park B, Salami SS, et al
    Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.